Literature DB >> 24418088

Expression and significance of E-cadherin, N-cadherin, transforming growth factor-β1 and Twist in prostate cancer.

Ge-Liang Liu1, Han-Jie Yang2, Tian Liu1, Yun-Zhao Lin3.   

Abstract

OBJECTIVE: To study the expression of E-cadherin, N-cadherin, TGF-β1 and Twist protein and investigate its significance in the occurrence and development of prostate cancer.
METHODS: The expression of E-cadherin, N-cadherin, TGF-β1 and Twist protein in 59 prostate cancer tissues and 21 adjacent tissues were detected by immunohistochemical SABC staining, and the correlation with clinicopathological features was analyzed.
RESULTS: Positive rates of E-cadherin, N-cadherin, TGF-β1 and Twist were 32.2%, 54.2%, 71.2% and 74.6%, respectively, in prostate cancer tissues and 85.7%, 9.52%, 19.0% and 9.52%, respectively, in cancer-adjacent tissues, with significant differences between the two groups (P<0.05). The reduced expression of E-cadherin was related to the differentiation of prostate cancer tissues and PSA level, but was not associated with clinical stage, lymph node metastasis, bony metastasis and age. The increased expression of N-cadherin, TGF-β1 and Twist was related to the differentiation of prostate cancer tissues, clinical stage, lymph node metastasis, bony metastasis, but not to age. The difference in positive expression of N-cadherin and TGF-β1 was significant between PSA≤20 μg/L group and PSA>20μg/L group, but the positive expression of Twist was not significant between groups. The expression of E-cadherin was highly negatively correlated with that of N-cadherin and also highly negatively correlated with that of Twist. The expression of TGF-β1 was correlated with those of E-cadherin, N-cadherin and Twist.
CONCLUSIONS: The reduced expression of E-cadherin, abnormal expression of N-cadherin, transformation form E-cadherin to N-cadherin and the increased expression of TGF-β1 and Twist play an important role in the occurrence and development of prostate cancer.
Copyright © 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  E-cadherin; Epithelial-mesenchymal transition; N-cadherin; Prostatic neoplams; TGF-β 1; Twist protein

Mesh:

Substances:

Year:  2014        PMID: 24418088     DOI: 10.1016/S1995-7645(13)60196-0

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  15 in total

1.  Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.

Authors:  Jiaqi Mi; Erika Hooker; Steven Balog; Hong Zeng; Daniel T Johnson; Yongfeng He; Eun-Jeong Yu; Huiqing Wu; Vien Le; Dong-Hoon Lee; Joseph Aldahl; Mark L Gonzalgo; Zijie Sun
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

2.  Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.

Authors:  Maahum Haider; Xiaotun Zhang; Ilsa Coleman; Nolan Ericson; Lawrence D True; Hung-Ming Lam; Lisha G Brown; Melanie Ketchanji; Belinda Nghiem; Bryce Lakely; Roger Coleman; Bruce Montgomery; Paul H Lange; Martine Roudier; Celestia S Higano; Jason H Bielas; Peter S Nelson; Robert L Vessella; Colm Morrissey
Journal:  Clin Exp Metastasis       Date:  2015-12-14       Impact factor: 5.150

3.  Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-β1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers.

Authors:  Taylan Turan; Meral Torun; Funda Atalay; Aymelek Gönenç
Journal:  Turk J Pharm Sci       Date:  2017-08-15

4.  Studying Tumor Angiogenesis and Cancer Invasion in a Three-Dimensional Vascularized Breast Cancer Micro-Environment.

Authors:  Madhuri Dey; Bugra Ayan; Marina Yurieva; Derya Unutmaz; Ibrahim T Ozbolat
Journal:  Adv Biol (Weinh)       Date:  2021-04-15

5.  SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells.

Authors:  Carolina M Vicente; Marcelo A Lima; Helena B Nader; Leny Toma
Journal:  J Exp Clin Cancer Res       Date:  2015-03-14

6.  Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.

Authors:  Kimberley Kolijn; Esther I Verhoef; Geert J L H van Leenders
Journal:  Oncotarget       Date:  2015-09-15

7.  T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance.

Authors:  Boris Dasen; Tatjana Vlajnic; Chantal Mengus; Christian Ruiz; Lukas Bubendorf; Giulio Spagnoli; Stephen Wyler; Paul Erne; Thérèse J Resink; Maria Philippova
Journal:  J Pathol Clin Res       Date:  2016-11-26

Review 8.  Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis.

Authors:  Yong Luo; Ting Yu; Qiongwen Zhang; Qingyu Fu; Yuzhu Hu; Mengmeng Xiang; Haoning Peng; Tianying Zheng; Li Lu; Huashan Shi
Journal:  Eur J Clin Invest       Date:  2018-02-25       Impact factor: 4.686

9.  Characteristics of bladder transitional cell carcinoma with E-cadherin and N-cadherin double-negative expression.

Authors:  Yang Luo; Yong-Tong Zhu; Li-Li Ma; Shi-Yu Pang; Li-Jie Wei; Cheng-Yong Lei; Cheng-Wu He; Wan-Long Tan
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

Review 10.  The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression.

Authors:  U-Ging Lo; Cheng-Fan Lee; Ming-Shyue Lee; Jer-Tsong Hsieh
Journal:  Int J Mol Sci       Date:  2017-09-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.